Tri-Continental Corp. Stock News

MINNEAPOLIS--(BUSINESS WIRE)--Tri-Continental Corporation (the “Corporation”) (NYSE: TY) today held its 94th Annual Meeting of Stockholders (the “Meeting”) in Minneapolis, Minnesota. Stockholders voted in favor of the recommendations of the Corporation's Board of Directors (the “Board”) on each of two proposals at the Meeting. Specifically, Stockholders re-elected Directors Kathleen Blatz, Pame...

BURLINGTON, Mass.--(BUSINESS WIRE)--PharmaEssentia USA Corporation, a subsidiary of PharmaEssentia Corporation (TWSE: 6446), a global biopharmaceutical innovator based in Taiwan leveraging deep expertise and proven scientific principles to deliver new biologics in hematology, oncology and immunology, today announced completion of enrollment for two clinical trials evaluating its ropeginterferon...

Tri-Continental Corporation offers exposure to domestic equity securities with a 3.82% yield, lower than peers but higher than American common equity indices. The TY closed-end fund's shares have gained 14.81% over the past five years, underperforming the S&P 500 but outperforming investment-grade bonds. The fund's portfolio primarily consists of common stocks, with an emphasis on high-yielding...

BOSTON--(BUSINESS WIRE)--Tri-Continental Corporation (the “Corporation”) (NYSE: TY) today declared a second quarter ordinary income distribution of $0.2905 per share of Common Stock and $0.6250 per share of Preferred Stock. In addition, the Corporation declared a total long-term capital gain distribution of $0.2878 per share of Common Stock. Distributions on Common Stock will be paid on June 18...